切换至 "中华医学电子期刊资源库"

中华肥胖与代谢病电子杂志 ›› 2018, Vol. 04 ›› Issue (03) : 168 -172. doi: 10.3877/cma.j.issn.2095-9605.2018.03.010

所属专题: 文献

综述

肠道菌群参与代谢综合征的机制研究进展
王迎伟1,(), 莫双阳1, 李运泽1   
  1. 1. 545000 柳州,广西科技大学附属柳州市人民医院消化内科
  • 收稿日期:2018-05-08 出版日期:2018-08-30
  • 通信作者: 王迎伟

Advances in the mechanism study on intestinal fl ora involvement in metabolic syndrome

Yingwei Wang1(), Shuangyang Mo1, Yunze Li1   

  • Received:2018-05-08 Published:2018-08-30
  • Corresponding author: Yingwei Wang
引用本文:

王迎伟, 莫双阳, 李运泽. 肠道菌群参与代谢综合征的机制研究进展[J/OL]. 中华肥胖与代谢病电子杂志, 2018, 04(03): 168-172.

Yingwei Wang, Shuangyang Mo, Yunze Li. Advances in the mechanism study on intestinal fl ora involvement in metabolic syndrome[J/OL]. Chinese Journal of Obesity and Metabolic Diseases(Electronic Edition), 2018, 04(03): 168-172.

[1]
Ley RE,Turnbaugh PJ,klein S, et al. Microbial ecology: human gut microbes associated with obesity[J]. Nature, 2006, 21444(12):1022-1023.
[2]
Hu Xu,Wang Tao,Jin Feng. Alzheimers disease and gut microbiota[J]. Science China Life Sciences, 2016, 59(10):1006-1023.
[3]
Mishra AK,Dubey V,Ghosh AR. Obesity: An overview of possible role(s) of gut hormones, lipid sensing and gut microbiota[J]. Metabolism, 2016, 65(1):48-65.
[4]
Devaraj S,Hemarajata P,Versalovic J. The human gut microbiome and body metabolism: implications for obesity and diabetes[J]. Clinical Chemistry, 2013, 59(4):617-628.
[5]
Louis S,Tappu RM,Damms-Machado A, et al. Characterization of the gut microbial community of obese patients following a weight-loss intervention using whole metagenome shothun sequencing[J]. PLoS One, 2016, 11(2):e0149564.
[6]
Turnbaugh PJ,Ley RE,Mahowald MA, et al. An obesity-associated gut microbiome with increased capacity for energy harvest[J].Nature, 2006, 444(7122):1027-1031.
[7]
Duca FA,Sakar Y,Covasa M, et al. Replication of obesity and associated singaling pathways through transfer of microbiota from obese-prone rats[J]. Diaetes, 2014, 63(5):1624-1636.
[8]
Chang CJ,Lin CS,Lu CC, et al. Ganoderma lucidum reduces obesity in mice by modulating the composition of the gut microbiota[J]. Nature Communication, 2015, 6(7489): 1.
[9]
Vrieze A,Van Nood E,Holleman F,et al. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome[J]. Gastroenterology, 2012, 143(4):913-916.e7.
[10]
Koeth RA,Wang Z,Levison, et al. Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis[J]. Nature Medicine, 2013, 19:576-585.
[11]
Warrier M,Shih DM,Burrows AC, et al. The TMAO-generating enzyme flavin monooxygenase 3 is a central regulator of cholesterol balance[J]. Cell Reports, 2015, 10:326-338.
[12]
Backhed F,Ding H,Wang T, et al. The gut microbiota as an environmental factor that regulates fat storage[J]. PNAS, 2004, 101(44): 15718.
[13]
Xu H,Barnes GT,Yang Q, et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance[J]. Journal of Clinical Investigation, 2003, 112(12): 1821-1830.
[14]
Aron-Wisnewsky J,Gaborit B,Dutour A, et al. Gut microbiota and non-alcoholic fatty liver disease: new insights[J]. Clinical Microbiology and Infection, 2013, 19(4): 338-348.
[15]
Janero DR,Lindsley L,Vemuri VK, et al. Cannabinoid 1G Protein-coupled receptor (periphero-) neutral antagonists: emerging therapeutics for treating obesity-driven metabolic diease and reducing cardiovascular risk[J]. Expert Opinion on Drug Discovery, 2011, 6(10): 995-1025.
[16]
Trillou CR,Delgorge C,Menet C, et al. CBI cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced onesity and enhanced leptin sensitivity[J]. Int J Obes(Lond), 2004, 28(4):640-648.
[17]
Cani PD,Delzenne NM. The role of the gut microbiota in energy metabolism and metabolic disease[J]. Current Pharmaceutical Design, 2009, 15(13):1546-1558.
[18]
Larsen N,Vogensen FK,Van den Berg FW, et al. Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults[J]. PLoS One, 2010, 5(2):e9085.
[19]
Zhang Xiuying,Shen Dongyuan,Fang Zhiwei, et al. Human gut microbiota changes reveal the progression of glucose intolerance[J]. PLoS One, 2013, 8(8):e71108.
[20]
Hartstra AV,Bouter KE,Nieuwdorp M, et al. Insights into the role of the microbiome in obesity and type 2 diabetes[J]. Diabetes Care, 2015, 38(1):159-165.
[21]
Qin Junjie,Li Yingrui,Wang Jun. A metagenome-wide association study of gut microbiota in tape 2 diabetes[J]. Nature, 2012, 490(7418):55-60.
[22]
Forslund K,Hildebrand F,Nielsen T, et al. Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota[J]. Nature, 2015, 528(7581):262.
[23]
Sato J,Kanazawa A,Ikeda F, et al. Gut dysbiosis and etection of "Live Gut Bacteria" in biood of Japanese patients with type 2 diabetes[J]. Diabetes Care, 2014, 37(8):2343-2350.
[24]
Hill JH,Franzosa EA,Huttenhower C,Guillemin K. A conserved bacterial protein induces pancreatic beta cell expansion during zebrafish development[J]. Elife, 2016, 13:5.
[25]
Batterham RL,Cowley MA,Small CJ, et al. Gut hormone PYY(3-36) physiologically inhibits food intake[J]. Nature, 2002, 418(6898):650-654.
[26]
Nadkarni P,Chepurny OG,Holz GG. Regulation of glucose homeostasis by GLP1[J]. Progress in Molecular Biology & Translational, 2014, 121:23-65.
[27]
Lin HV,Frassetto A,Kowalik EJ Jr, et al. Butyrate and propionate protect against diet-induced obesity and regulate gut hormones via free fatty acid receptor 3-independent mechanisms[J]. PLoS One, 2012, 7(4):e35240.
[28]
Cani PD,Amar J,Iglesias MA, et al. Metabolic endotoxemia initiates obesity and insulin resistance[J]. Diabetes, 2007, 56(7):1761-1772.
[29]
Caricilli AM,Picardi PK,de Abreu LL, et al. Gut microbiota Is a key modulator of insulin resistance in TLR 2 knockout mice[J]. PLoS Biology, 2011, 9(12):e1001212.
[30]
Li Fei,Jiang Changtao,Krausz KW, et al. Microbiome remodeling leads to inhibition of intestinal farnesoid X receptor signaling and decreased obesity[J]. Nature Communication, 2013, 4:2384.
[31]
Stenman LK,Holma R,Korpela R. High-fat-induced intestinal permeability dysfunction associated with altered fecal bile acids[J]. World J Gastroenterol, 2012, 18(9):923-929.
[32]
Yang T,Santisteban MM,Rodriguez V, et al. Gut dysbiosis is linked to hypertension[J]. Hypertension, 2015, 65(6):1331-1340.
[33]
Nutting CW,Islam S,Daugirdas JT. Vasorelaxant effect of short chain fatty acid salts in rat caudal artery[J]. American Journal of Physiology, 1991, 261:H561-567.
[34]
Holmes E,Loo RL,Stamler J, et al. Human metabolic phenotype diversity and its association with diet and blood pressure[J]. Nature, 2008, 453:396-400.
[35]
Gomez-Guzman M,Toral M,Romero M, et al. Antihypertensive effects of probiotics Lactobacillus strains in spontaneously hypertensive rats[J]. Molecular Nutrition & Food Research, 2015, 59(11):2326-2336.
[36]
Forythe P,Kunze W,Bienenstock J. Moody microbes or fecal phrenology: what do we know about the microbiota-gut-brain axis[J]. BMC Medicine, 2016, 14(1):58.
[37]
Angelakis E,Armougom F,Million M, et al. The relationship between gut microbiota and weight gain in human[J]. Future Microbiol, 2012, 7(1):91-109.
[38]
Manzanares W,Lemieux M,Langlois PL, et al. Probiotic and symbiotic therapy incritical illness[J]. Critical Care, 2016, 20(1):262.
[39]
Everard A,Lazarevic V,Derrien M, et al. Responses of gut microbiota and glucose and lipid metabolism to prebiotics in genetic obese and diet-induced leptin-resistant mice[J]. Diabetes, 2011, 60(11):2775-2786.
[40]
Bakken JS,Borody T,Brandt LJ, et al. Treating Clostridium difficile infection with fectal microbiota transplantion[J]. Clin Gastroenterol Hepatol, 2011, 9(12):1044-1049.
[41]
Young VB. Treatment with fecal microbiota transplantation: the need for complete methodological reporting for clinical trials[J]. Annals of Internal Medicine, 2017.doi:10.7326/M17-1157.
[42]
Khoruts A,Weingarden AR. Emergence of fecal microbiota transplantation as an approach to repair disrupted microbial gut ecology[J].Immunology Letters, 2014, 162(2 Pt A):77-81.
[43]
Woodard GA,Encarnacion B,Downey JR, et al. Probiotics improve outcomes after Roux-en-Y gastric bypass surgery: a prospective randomized trial[J]. Journal of Gastrointestinal Surgery, 2009, 13(7):1198-1204.
[44]
Liou AP,Paziuk M,Luevano JM, et al. Conserved shifts in the gut microbiota due to gastric bypass reduce host weight and adiposity[J]. Science Translational Medicine, 2013, 5(178):178ra41.
[1] 杨瑾, 刘雪克, 张媛媛, 金钧, 韦瑶. 肠道微生物来源石胆酸对脓毒症相关肝损伤的保护作用[J/OL]. 中华危重症医学杂志(电子版), 2024, 17(04): 265-274.
[2] 戴睿, 张亮, 陈浏阳, 张永博, 吴丕根, 孙华, 杨盛, 孟博. 肠道菌群与椎间盘退行性变相关性的研究进展[J/OL]. 中华损伤与修复杂志(电子版), 2024, 19(06): 546-549.
[3] 李嘉兴, 孙乙文, 李文星. NLRP3炎性小体在急性胰腺炎中作用的研究进展[J/OL]. 中华普通外科学文献(电子版), 2024, 18(04): 300-304.
[4] 李玲, 刘亚, 李培玲, 张秀敏, 李萍. 直肠癌患者术后肠道菌群的变化与抑郁症相关性研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 607-610.
[5] 王雪玲, 曹欢, 顾劲扬. 肠道菌群在器官缺血再灌注损伤中的作用及机制研究进展[J/OL]. 中华移植杂志(电子版), 2024, 18(04): 247-250.
[6] 陆婷, 陈浩, 王雪静, 谭若芸, 彭宇竹. 肾移植术后一年发生代谢综合征的危险因素分析[J/OL]. 中华移植杂志(电子版), 2024, 18(02): 98-103.
[7] 方道成, 唐春华, 胡媛媛. 肠道菌群对草酸钙肾结石形成的影响[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(05): 509-513.
[8] 蔡艺丹, 方坚, 张志强, 陈莉, 张世安, 夏磊, 阮梅, 李东良. 经颈静脉肝内门体分流术对肝硬化门脉高压患者肠道菌群及肝功能的影响[J/OL]. 中华细胞与干细胞杂志(电子版), 2024, 14(05): 285-293.
[9] 赵小民, 杨军, 田巍巍. 枳术颗粒联合利那洛肽治疗便秘型肠易激综合征的临床研究[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(05): 465-469.
[10] 邱岭, 朱旭丽, 浦坚, 邢苗苗, 吴佳玲. 糖尿病肾病患者肠道菌群生态特点与胃肠道功能障碍的关联性研究[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(05): 453-458.
[11] 宋燕秋, 戚桂艳, 杨双双, 周萍. 重症急性胰腺炎肠道菌群特征及早期肠内营养联合微生态制剂治疗的临床价值[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(05): 442-447.
[12] 谢鸿, 李娜, 李尚日, 谢涛. 肠道菌群特征对结肠癌化学治疗疗效的影响[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(01): 53-56.
[13] 韦美菊, 潘玲. 肠道菌群-胆汁酸代谢轴在慢性肾脏病中的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(02): 219-222.
[14] 何玉花, 钟欢妹, 王文惠, 沈永棋, 刘映云, 顾国威, 陈丹娜. 不同表型多囊卵巢综合征患者代谢指标及肥胖相关指标对多囊卵巢综合征合并代谢综合征人群的诊断效能分析[J/OL]. 中华临床实验室管理电子杂志, 2024, 12(04): 212-220.
[15] 张鑫, 刘志芬, 郭云童. 肥胖与抑郁症相关性的研究进展[J/OL]. 中华肥胖与代谢病电子杂志, 2024, 10(04): 255-260.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?